Stockreport

Protalix BioTherapeutics to Hold Fourth Quarter and Full-Year 2019 Financial and Business Results Conference Call on March 12, 2020

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF CARMIEL, Israel, March 5, 2020 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, p [Read more]